Carlo Rosa is Chief Executive Officer of the Diasorin Group.
Born in 1966, he graduated in 1990 in Chemistry cum laude from the University of Turin.
In 1990, he moved to New York to work at the Health Research Institute on a project to develop a new innovative product for the diagnosis of hepatitis C infections.
In 1992, he joined the listed American Incstar Corporation (Minnesota), where he worked in the Research and Development department and led a joint venture project with Akzo Nobel. Subsequently, he held other positions, both in the Research sector and in Strategic Marketing, until assuming the role of Director of the Infectious Diseases Business Unit.
In 1998, he returned to Italy to take on the role of Director of Strategy and Marketing Europe for DiaSorin S.p.A.
In 2000 he led a management buyout with other executives and a group of financial investors to buy Diasorin from the previous owner, American Standard Inc. Following the transaction, he served as Chief Operating Officer until 2006, when he became CEO of the Group, a position he still holds.
In 2016, he was elected Vice President of Assobiotec and joined the Italian Institute of Technology Foundation as a Board Member.